論文・総説 - 稲澤　譲治

分割表示  519 件中 21 - 40 件目  ／  全件表示 >>

  1. Inoue J, Kishikawa M, Tsuda H, Nakajima Y, Asakage T, Inazawa J. Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma. Cancer science. 2021.07; 112 (7): 2792-2802. ( PubMed, DOI )

  2. Kishikawa M, Inoue J, Hamamoto H, Kobayashi K, Asakage T, Inazawa J. Augmentation of lenvatinib efficacy by topical treatment of <i>miR-634</i> ointment in anaplastic thyroid cancer. Biochemistry and biophysics reports. 2021.07; 26 101009. ( PubMed, DOI )

  3. Inoue Jun, Kishikawa Masahiro, Tsuda Hitoshi, Nakajima Yasuaki, Asakage Takahiro, Inazawa Johji. 食道扁平上皮癌に対する代謝標的治療においてPDHX遺伝子の特定(Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma) Cancer Science. 2021.07; 112 (7): 2792-2802. ( 医中誌 )

  4. Nishino K, Yoshimatsu Y, Muramatsu T, Sekimoto Y, Mitani K, Kobayashi E, Okamoto S, Ebana H, Okada Y, Kurihara M, Suzuki K, Inazawa J, Takahashi K, Watabe T, Seyama K. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis. Scientific reports. 2021.04; 11 (1): 8406. ( PubMed, DOI )

  5. Xu B, Muramatsu T, Inazawa J. Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell Growth. Molecular cancer research : MCR. 2021.04; 19 (4): 585-597. ( PubMed, DOI )

  6. Inoue Jun, Kishikawa Masahiro, Asakage Takahiro, Inazawa Johji. Exploring metabolic therapeutic targets for esophageal squamous cell carcinoma CANCER SCIENCE. 2021.02; 112 385.

  7. Liu Chang, Gen Yasuyuki, Inazawa Johji. miR-3140 suppressed tumor cell growth in neuroblastoma by targeting BRD4-MYCN pathway CANCER SCIENCE. 2021.02; 112 579.

  8. Muramatsu Tomoki, Xu Bo, Inazawa Johji. Pitavastatin inhibits the tumor growth through the suppression of AKT and ERK signals in oral and esophageal cancer CANCER SCIENCE. 2021.02; 112 285.

  9. Gen Yasuyuki, Inazawa Johji. Nucleic acid therapeutics using a novel tumor-suppressive microRNA targeting MYC pathway CANCER SCIENCE. 2021.02; 112 647.

  10. Takata Ryo, Akamatsu Shusuke, Nakagawa Hidewaki, Takahashi Atsushi, Egawa Shin, Kamatani Yoichiro, Inazawa Johji, Ogawa Osamu, Obara Wataru. Identification of twelve new susceptibility loci and polygenic risk for prostate cancer in Japanese population CANCER SCIENCE. 2021.02; 112 321.

  11. Inazawa Johji. Genomics/Genetics in the era of Precision Cancer Medicine (PCM) CANCER SCIENCE. 2021.02; 112 233.

  12. Beck DB, Basar MA, Asmar AJ, Thompson JJ, Oda H, Uehara DT, Saida K, Pajusalu S, Talvik I, D'Souza P, Bodurtha J, Mu W, Barañano KW, Miyake N, Wang R, Kempers M, Tamada T, Nishimura Y, Okada S, Kosho T, Dale R, Mitra A, Macnamara E, Undiagnosed Diseases Network., Matsumoto N, Inazawa J, Walkiewicz M, Õunap K, Tifft CJ, Aksentijevich I, Kastner DL, Rocha PP, Werner A. Linkage-specific deubiquitylation by OTUD5 defines an embryonic pathway intolerant to genomic variation. Science advances. 2021.01; 7 (4): ( PubMed, DOI )

  13. Inoue J, Fujiwara K, Hamamoto H, Kobayashi K, Inazawa J. Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with <i>miR-634</i> Ointment. Molecular therapy oncolytics. 2020.12; 19 294-307. ( PubMed, DOI )

  14. Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H, Sakaue S, Matoba N, Low SK, Okada Y, Terao C, Amariuta T, Gazal S, Kochi Y, Horikoshi M, Suzuki K, Ito K, Koyama S, Ozaki K, Niida S, Sakata Y, Sakata Y, Kohno T, Shiraishi K, Momozawa Y, Hirata M, Matsuda K, Ikeda M, Iwata N, Ikegawa S, Kou I, Tanaka T, Nakagawa H, Suzuki A, Hirota T, Tamari M, Chayama K, Miki D, Mori M, Nagayama S, Daigo Y, Miki Y, Katagiri T, Ogawa O, Obara W, Ito H, Yoshida T, Imoto I, Takahashi T, Tanikawa C, Suzuki T, Sinozaki N, Minami S, Yamaguchi H, Asai S, Takahashi Y, Yamaji K, Takahashi K, Fujioka T, Takata R, Yanai H, Masumoto A, Koretsune Y, Kutsumi H, Higashiyama M, Murayama S, Minegishi N, Suzuki K, Tanno K, Shimizu A, Yamaji T, Iwasaki M, Sawada N, Uemura H, Tanaka K, Naito M, Sasaki M, Wakai K, Tsugane S, Yamamoto M, Yamamoto K, Murakami Y, Nakamura Y, Raychaudhuri S, Inazawa J, Yamauchi T, Kadowaki T, Kubo M, Kamatani Y. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nature genetics. 2020.07; 52 (7): 669-679. ( PubMed, DOI )

  15. Takagawa Y, Gen Y, Muramatsu T, Tanimoto K, Inoue J, Harada H, Inazawa J. miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway. Molecular therapy : the journal of the American Society of Gene Therapy. 2020.06; 28 (6): 1494-1505. ( PubMed, DOI )

  16. Takahashi Kenta, Gen Yasuyuki, Tanimoto Kousuke, Kudo Atsushi, Oshima Noriko, Ban Daisuke, Takemoto Akira, Onishi Iichiro, Kumaki Yuichi, Yokobori Junko, Takamine Eriko, Kano Yoshihito, Miyake Satoshi, Miyasaka Naoyuki, Tanabe Minoru, Inazawa Johji, Ikeda Sadakatsu. Clinical impact of hemizygous deletion detection and panel-size in comprehensive genomic profiling. JOURNAL OF CLINICAL ONCOLOGY. 2020.05; 38 (15):

  17. Gokita K, Inoue J, Ishihara H, Kojima K, Inazawa J. Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy. Molecular therapy. Nucleic acids. 2020.03; 19 330-338. ( PubMed, DOI )

  18. Matsukawa T, Yamamoto T, Honda A, Toya T, Ishiura H, Mitsui J, Tanaka M, Hao A, Shinohara A, Ogura M, Kataoka K, Seo S, Kumano K, Hosoi M, Narukawa K, Yasunaga M, Maki H, Ichikawa M, Nannya Y, Imai Y, Takahashi T, Takahashi Y, Nagasako Y, Yasaka K, Mano KK, Matsukawa MK, Miyagawa T, Hamada M, Sakuishi K, Hayashi T, Iwata A, Terao Y, Shimizu J, Goto J, Mori H, Kunimatsu A, Aoki S, Hayashi S, Nakamura F, Arai S, Momma K, Ogata K, Yoshida T, Abe O, Inazawa J, Toda T, Kurokawa M, Tsuji S. Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy. Brain communications. 2020; 2 (1): fcz048. ( PubMed, DOI )

  19. Tanimoto K, Muramatsu T, Inazawa J. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas. Cancer medicine. 2019.12; 8 (17): 7372-7384. ( PubMed, DOI )

  20. Hirabayashi K, Uehara DT, Abe H, Ishii A, Moriyama K, Hirose S, Inazawa J. Copy number variation analysis in 83 children with early-onset developmental and epileptic encephalopathy after targeted resequencing of a 109-epilepsy gene panel. Journal of human genetics. 2019.11; 64 (11): 1097-1106. ( PubMed, DOI )

< 前のページ - 次のページ >

このページの先頭へ▲